Minimal Polymerase-Containing Precursor Required for Chikungunya Virus RNA Synthesis

Area of Science:

• Virology
• Molecular Biology
• Biochemistry

Background:

• Alphaviruses, including Chikungunya virus (CHIKV), represent a significant global health concern with ongoing epidemics.
• Current CHIKV vaccine development has not yet resulted in licensure or widespread availability.
• The nsP2 protease and nsP4 RNA-dependent RNA polymerase (RdRp) of CHIKV are crucial for viral replication and represent key targets for antiviral therapies, but the biochemical function of nsP4 is not well understood.

Purpose of the Study:

• To investigate the biochemical basis of nsP4 RNA-dependent RNA polymerase (RdRp) activity in Chikungunya virus (CHIKV).
• To identify and characterize a functional precursor form of nsP4 involved in viral RNA replication.
• To establish a framework for understanding the assembly, activation, and regulation of the alphavirus polymerase.

Main Methods:

• Utilized a cell-based RNA replicon system to study CHIKV nsP4 activity.
• Employed synthetic, capped mRNAs to assess the role of nsP2 protease cleavage in P34 polyprotein processing.
• Investigated the replication efficiency of truncated nsP4 precursor forms, including CT50-P34.

Main Results:

• Identified a minimal, functional precursor form of nsP4 (P34) active in a cell-based system.
• Demonstrated that cleavage of P34 by the nsP2 protease is essential for robust reporter gene expression.
• Showed that a truncated P34 form (CT50-P34) supports near-wild-type replication, indicating its functional significance.

Conclusions:

• Proposed a model where precursor nsP4 interacts with the nsP1 dodecamer for activation at replication sites.
• Suggested that nsP1 dodecamer binding maintains nsP4 in an active conformation, while dissociation leads to inactivation.
• Established a tractable system for further study of alphavirus polymerase assembly, activation, and regulation, aiding antiviral development.